Identification of autoantibodies elicited in a patient with prostate cancer presenting as dermatomyositis

International Journal of Urology

Volumn 13, Issue 3, 2006, Pages 211-217

  Mooney, Colin J ^a   Dunphy, Edward J ^a   Stone, Brad ^b   McNeel, Douglas G ^a,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c University of Wisconsin Health   (United States)

Author keywords

Autoantibody; Dermatomyositis; Prostate cancer; SEREX

Indexed keywords

ACETYL COENZYME A ACYLTRANSFERASE; ALDOLASE C; AUTOANTIBODY; AUTOANTIGEN; BICALUTAMIDE; COMPLEMENTARY DNA; ELONGATION FACTOR 1ALPHA; EUKARYOTIC TRANSLATION ELONGATION FACTOR 1ALPHA 1; IMMUNOGLOBULIN G; LEUPRORELIN; MUSCLE PROTEIN; PREDNISONE; PROSTATE PROTEIN; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

AGED; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; BACTERIOPHAGE LAMBDA; BREAST CANCER; CASE REPORT; DERMATOMYOSITIS; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; MALE; MUSCLE TISSUE; MUSCLE WEAKNESS; OVARY CANCER; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROTEIN EXPRESSION; RASH;

ADENOCARCINOMA; AGED; ANTIBODIES, ANTI-IDIOTYPIC; DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 33645450687     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01263.x     Document Type: Article

References (36)

1. Jemal A Murray T Ward E et al. Cancer statistics, 2005. CA Cancer J. Clin. 2005 55 10 30.
2. Sim HG Cheng CW. Changing demography of prostate cancer in Asia. Eur J. Cancer 2005 41 834 45.
3. Kaufman HL Wang W Manola J et al. Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): a trial of the Eastern Cooperative Oncology Group. J. Clin. Oncol. 2004 22 2122 32.
4. Small EJ Fratesi P Reese DM et al. Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells. J. Clin. Oncol. 2000 18 3894 903.
5. Burch PA Breen JK Buckner JC et al. Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer. Clin. Cancer Res. 2000 6 2175 82.
6. Murphy GP Tjoa BA Simmons SJ et al. Phase II prostate cancer vaccine trial: report of a study involving 37 patients with disease recurrence following primary treatment. Prostate 1999 39 54 9.
7. McNeel DG Nguyen LD Storer BE Vessella R Lange PH Disis ML. Antibody immunity to prostate cancer-associated antigens can be detected in the serum of patients with prostate cancer. J. Urol. 2000 164 1825 9.
8. McNeel DG Nguyen LD Ellis WJ Higano CS Lange PH Disis ML. Naturally occurring prostate cancer antigen-specific T cell responses of a Th1 phenotype can be detected in patients with prostate cancer. Prostate 2001 47 222 9.
9. McNeel DG. Prostate cancer antigens and vaccines, preclinical developments. In Giaccone G Schilsky R and Sondel P (eds). pubtl Cancer Chemother. Biol. Response Modif. Elsevier Amsterdam 2005 247 61.
10. Seelig HP Moosbrugger I Ehrfeld H Fink T Renz M Genth E. The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation. Arthritis Rheum. 1995 38 1389 99.
11. Zhang Y LeRoy G Seelig HP Lane WS Reinberg D. The dermatomyositis- specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 1998 95 279 89.
12. Mimori T. Autoantibodies in connective tissue diseases: clinical significance and analysis of target autoantigens. Intern. Med. 1999 38 523 32.
13. Buchbinder R Hill CL. Malignancy in patients with inflammatory myopathy. Curr. Rheumatol. Rep. 2002 4 415 26.
14. Ansai S Koseki S Takeda H Kondo S Yamakawa M. Dermatomyositis accompanied by prostatic cancer and elevated serum CA 19.9. Int. J. Dermatol. 1996 35 570 1.
15. Rapoport AH Omenn GS. Dermatomyositis and malignant effusions: rare manifestations of carcinoma of the prostate. J. Urol. 1968 100 183 7.
16. Otnes B Refsum SB Husby G Mathisen W. Probable endometrial carcinoma of the prostate, crossed renal ectopia and dermatomyositis in a 32-year-old man. J. Urol. 1978 120 504 7.
17. Machtey I. Polymyositis associated with carcinoma of the prostate. J. Am. Geriatr. Soc. 1970 18 250 5.
18. Joseph JV Turner KJ Bramwell SP. Dermatomyositis: a rare initial presentation of adenocarcinoma of the prostate. J. Urol. 2002 168 637.
19. Masuda H Urushibara M Kihara K. Successful treatment of dermatomyositis associated with adenocarcinoma of the prostate after radical prostatectomy. J. Urol. 2003 169 1084.
20. Sekine Y Kubota Y Kurihara J. A case of dermatomyositis associated with prostatic carcinoma: a case report. Hinyokika Kiyo 2004 50 95 7. (In Japanese.)
21. Bessonov IA. Dermatomyositis associated with carcinoma of the prostate and esophagus. Vrach Delo 1971 12 99 101. (In Russian.)
22. Subramonian K Sundaram SK MacDonald Hull SP. Carcinoma of the prostate associated with dermatomyositis. BJU Int. 2000 86 401 2.
23. Dunphy EJ Eickhoff JC Muller CH Berger RE McNeel DG. Identification of antigen-specific IgG in sera from patients with chronic prostatitis. J. Clin. Immunol. 2004 24 492 501.
24. Dunphy EJ McNeel DG. Antigen-specific IgG elicited in subjects with prostate cancer treated with flt3 ligand. J. Immunother. 2005 28 268 75.
25. Sahin U Tureci O Schmitt H et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl Acad. Sci. USA. 1995 92 11 10 13.
26. Altschul SF Madden TL Schaffer AA et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997 25 3389 402.
27. Hill CL Zhang Y Sigurgeirsson B et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001 357 96 100.
28. Stuhlmuller B Jerez R Hausdorf G et al. Novel autoantibodies against muscle-cell membrane proteins in patients with myositis. Arthritis Rheum. 1996 39 1860 8.
29. Paolella G Buono P Mancini FP Izzo P Salvatore F. Structure and expression of mouse aldolase genes. Brain-specific aldolase C amino acid sequence is closely related to aldolase A. Eur J. Biochem. 1986 156 229 35.
30. Baker R. Serum aldolase and its relationship to the hormonal control of cancer. J. Urol. 1953 69 426 32.
31. Verlooy J van Sande M Van Camp K. Aldolase activity in benign prostatic hypertrophy and adenocarcinomatous prostate. Acta Urol. Belg. 1980 48 65 7.
32. Solway J Seltzer J Samaha FF et al. Structure and expression of a smooth muscle cell-specific gene, SM22 alpha. J. Biol. Chem. 1995 270 13460 9.
33. Untergasser G Gander R Lilg C Lepperdinger G Plas E Berger P. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation. Mech. Ageing Dev. 2005 126 59 69.
34. Lee S Wolfraim LA Wang E. Differential expression of S1 and elongation factor-1 alpha during rat development. J. Biol. Chem. 1993 268 24 53 9.
35. Hasegawa H Uchiumi T Sato T Saito A Nakano M Gejyo F. Autoantibody against ribosomal protein L14 in patients with systemic lupus erythematosus. Clin. Exp. Rheumatol. 2002 20 139 44.
36. Arora S Yang JM Craft J Hait W. Detection of anti-elongation factor 2 kinase (calmodulin-dependent protein kinase III) antibodies in patients with systemic lupus erythematosus. Biochem. Biophys. Res. Commun. 2002 293 1073 6.